Sightsavers – in participation with SBI Capital Markets - have jointly set up a total of three mobile vision centers in the urban cities of India, namely Chennai, Kolkata, and Pune to provide primary eye care examination for the people with low financial income, according to a news covered by the local media.
Efforts to share research with the public must include mechanisms to prevent harm resulting from low-quality work.
Far from being inferior, smaller universities can outstrip elite ones in research training and promoting inclusivity.
Scientists from Nanyang Technological University, Singapore (NTU Singapore), in collaboration with clinicians at Tan Tock Seng Hospital (TTSH) in Singapore have developed a novel method that uses artificial intelligence (AI) to screen for glaucoma, a group of eye diseases that can cause vision loss and blindness through damage to the optic nerve at the back of the eye.
The newly formed government organization tackled 46 research-fraud investigations in 2020 — three times as many as expected.
OD-OS’s teleguidance offering addresses the lack of experts and also benefits teaching in retina laser care.
Students who received eyeglasses through a school-based program scored higher on reading and math tests, Johns Hopkins researchers from the Wilmer Eye Institute and School of Education found in the largest clinical study of the impact of glasses on education ever conducted in the United States. The students who struggled the most academically showed the greatest improvement.
Although the gap is narrowing, prestigious prizes are still more likely to go to men, finds an analysis of gender bias in the world’s top science awards.
The departing German chancellor’s support for science and rigour in policymaking has proved transformative — except on climate change.
The Ophthalmology Foundation is a recently formed nonprofit organization created to support ophthalmic education internationally—particularly in low-resource and underserved countries—to improve global eye care, advance scientific ophthalmology, and ultimately preserve and restore vision for people of all nations.
Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world, unveiled additional ophthalmic drug candidates (VT-201) with applications in development for corneal wound healing, glaucoma and age-related macular degeneration (AMD).
Automated direct selective laser trabeculoplasty appears to reduce IOP in patients with primary open-angle glaucoma, according to a speaker here.
Using smartphones for eye screening and referrals could triple the number of people seeking primary care for eye problems and increase the uptake of hospital services in low-resource settings, a study says.
After an existential crisis, we realized we needed to think more deeply about our careers
We need EU research and innovation to ensure a sustainable Europe